文献速递淋巴瘤

伯基特淋巴瘤肿瘤浸润TCR库多样性耗竭与年龄相关并独立预测临床结局

Exhaustion of tumour-infiltrating T-cell receptor repertoire diversity is an age-dependent indicator of immunological fitness independently predictive of clinical outcome in Burkitt lymphoma.
PubMed 文献 · Br J Haematol · 2020-09-18

该研究对82例伯基特淋巴瘤和34例弥漫大B细胞淋巴瘤患者进行TCRβ链CDR3区二代测序,发现伯基特淋巴瘤存在年龄依赖性免疫特征及共享克隆型,复发时TCR库显著受限,生产性TCR库克隆性可预测总生存和无进展生存且独立于既定预后因素。

要点

  • 伯基特淋巴瘤TCR库呈现年龄依赖性免疫特征
  • TCR库克隆性独立预测总生存和无进展生存

核心结论

  • 伯基特淋巴瘤TCR库结构与克隆性具有临床相关性,其年龄决定动态可独立预测临床结局。

研究设计与样本

  • 对82例伯基特淋巴瘤(涵盖所有流行病学亚型)和34例弥漫大B细胞淋巴瘤患者进行TCRβ链CDR3区大规模二代测序,并将分子数据与临床结局进行相关性分析。

主要发现

  • 伯基特淋巴瘤与弥漫大B细胞淋巴瘤均呈现年龄依赖性免疫特征。
  • 在多名患者中发现若干共享克隆型,提示伯基特淋巴瘤存在共享肿瘤新抗原选择,且独立于EB病毒和/或HIV状态,与弥漫大B细胞淋巴瘤不同。
  • 多因素分析证实其独立于既定预后因素,包括诊断时年龄和合并症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Burkitt lymphoma (BL) is an aggressive B-cell-malignancy derived from germinal-centre B-cells. Curative therapy traditionally requires intensive immunochemotherapy. Recently, immuno-oncological approaches, modulating the T-cell tumour response, were approved for the treatment of a variety of malignancies. The architecture of the tumour-infiltrating T-cell receptor (TCR) repertoire in BL remains insufficiently characterized. We therefore performed a large-scale, next-generation sequencing study of the complimentary-determining region (CDR)-3 region of the TCRβ chain repertoire in a large cohort of all epidemiological subtypes of BL (n = 82) and diffuse large B-cell lymphoma (DLBCL; n = 34). Molecular data were subsequently assessed for correlation with clinical outcome. Our investigations revealed an age-dependent immunoprofile in BL as in DLBCL. Moreover, we found several public clonotypes in numerous patients suggestive of shared tumour neoantigen selection exclusive to BL and distinct from DLBCL regardless of Epstein-Barr virus and/or human immunodeficiency virus status. Compared with baseline, longitudinal analysis unveiled significant repertoire restrictions upon relapse (P = 0·0437) while productive TCR repertoire clonality proved to be a useful indicator of both overall and progression-free-survival [OS: P = 0·0001; hazard ratio (HR): 6·220; confidence interval (CI): 2·263-11·78; PFS: P = 0·0025; HR: 3·086; CI: 1·555-7·030]. Multivariate analysis confirmed its independence from established prognosticators, including age at diagnosis and comorbidities. Our findings establish the clinical relevance of the architecture and clonality of the TCR repertoire and its age-determined dynamics in BL.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Rieken J, Bernard V, Witte HM, et al. Exhaustion of tumour-infiltrating T-cell receptor repertoire diversity is an age-dependent indicator of immunological fitness independently predictive of clinical outcome in Burkitt lymphoma. Br J Haematol. 2020. PMID: 32945554. doi:10.1111/bjh.17083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。